Does Insurance Cover Tigecycline Generics?
Yes, tigecycline generics are typically covered by insurance, including Medicare Part D, Medicaid, and most commercial plans, though coverage varies by plan, pharmacy, and prior authorization requirements. As a generic antibiotic approved since 2017, it faces lower copays—often $10–$50 for a course—compared to the brand Tygacil, which can exceed $2,000 per dose without coverage.[1]
How Much Do Patients Pay Out-of-Pocket?
Copays for generic tigecycline average $20–$60 for a 100 mg vial or full treatment course (6–14 days), depending on the insurer. Medicare beneficiaries pay around 25% coinsurance after the deductible, capped at $2,000 annually via Part D. Tools like GoodRx show cash prices as low as $150–$300 per course without insurance, making it accessible even if coverage is denied.[2]
Which Insurances Commonly Cover It?
- Medicare Part D: Listed on most formularies as Tier 2 or 3 (generics), with 90%+ plan coverage. Requires quantity limits for hospital use.
- Medicaid: Covered in all states for approved infections like complicated skin infections or intra-abdominal infections.
- Commercial (e.g., Blue Cross, UnitedHealthcare): High coverage rates (85–95%), but some plans need step therapy (try cheaper antibiotics first) or PA for resistant infections.
Hospital-administered tigecycline often falls under medical benefits, fully covered for inpatients.[3]
When Might Coverage Be Denied?
Denials occur if deemed non-preferred, for off-label use (e.g., non-FDA-approved infections), or without PA. High-risk patients with multidrug-resistant infections face fewer hurdles due to limited alternatives. Appeal success is high (70%+) with physician documentation.[4]
Tigecycline Patent Status and Generic Availability
All U.S. tigecycline patents expired by 2015–2017, enabling multiple generics from manufacturers like Mylan, Sandoz, and Apotex. No active Orange Book patents block competition, keeping prices low and insurance-friendly.[5]
Cheaper Alternatives If Not Covered
| Drug | Coverage Notes | Avg. Generic Cost/Course |
|------|----------------|--------------------------|
| Meropenem | Broad Medicare/commercial coverage | $100–$400 |
| Ertapenem | Preferred on most plans | $50–$200 |
| Piperacillin-tazobactam | Tier 1 generic, minimal copays | $20–$100 |
These IV antibiotics treat similar resistant infections with comparable insurance approval rates.[6]
Sources
[1]: CMS Medicare Part D Formulary
[2]: GoodRx Tigecycline Pricing
[3]: FDA Orange Book - Tigecycline Generics
[4]: ASHP Coverage Guidelines
[5]: DrugPatentWatch.com - Tigecycline Patents
[6]: IDSA Guidelines on Resistant Infections